Literature DB >> 7420023

Central pyrogenic activity of muramyl dipeptide.

G Riveau, K Masek, M Parant, L Chedid.   

Abstract

Fever can be elicited in the rabbit by the intravenous administration of relatively large doses of a synthetic immunoadjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine, or muramyl dipeptide (MDP). This response could be mediated by endogenous pyrogen because MDP has been shown to induce their production both in vivo and in vitro. The results reported here show that intracisternal injection of minute amounts of MDP could elevate fever without activating the release of endogenous pyrogen in the plasma or in the cerebrospinal fluid. Moreover, indomethacin inhibited hyperthermia produced by intracerebroventricular administration of MDP. Therefore, our findings argue in favor of a direct effect of the glycopeptide on the thermoregulatory centers besides its indirect effect through the production of leukocytic pyrogen. This molecule apparently represents the minimal requirement for the pyrogenicity of bacterial peptidoglycan because administration, even by the intracerebral route, of a mixture of muramic acid and of its dipeptide moiety did not elicit fever.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7420023      PMCID: PMC2185958          DOI: 10.1084/jem.152.4.869

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Modern views on the pathogenesis of fever and the mode of action of antipyretic drugs.

Authors:  A S Milton
Journal:  J Pharm Pharmacol       Date:  1976-04       Impact factor: 3.765

2.  Modulation of the immune response by a synthetic adjuvant and analogs.

Authors:  L Chedid; F Audibert; P Lefrancier; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

3.  Gelation of the amoebocyte lysate of Tachypleus tridentatus by cell wall digest of several gram-positive bacteria and synthetic peptidoglycan subunits of natural and unnatural configurations.

Authors:  S Kotani; Y Watanabe; F Kinoshita; K Kato; K Harada
Journal:  Biken J       Date:  1977-03

Review 4.  Pathogenesis of fever in man.

Authors:  C A Dinarello; S M Wolff
Journal:  N Engl J Med       Date:  1978-03-16       Impact factor: 91.245

5.  On the mechanism of fever caused by the mucopeptide of group A streptococcus.

Authors:  K Masek; H Rasková; J Rotta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  Synthesis of N-acetyl-muramyl-L-alanyl-D-isoglutamine, an adjuvant of the immune response, and of some n-acetyl-muramyl-peptide analogs.

Authors:  P Lefrancier; J Choay; M Derrien; I Lederman
Journal:  Int J Pept Protein Res       Date:  1977

7.  Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock.

Authors:  P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

8.  The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.

Authors:  C A Dinarello; R J Elin; L Chedid; S M Wolff
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

9.  Study on the possible entry of bacterial endotoxin and prostaglandin E2 into the central nervous system from the blood.

Authors:  M J Dascombe; A S Milton
Journal:  Br J Pharmacol       Date:  1979-08       Impact factor: 8.739

10.  Studies on the pathogenesis of fever. II. Identification of an endogenous pyrogen in the blood stream following the injection of typhoid vaccine.

Authors:  E ATKINS; W B WOOD
Journal:  J Exp Med       Date:  1955-11-01       Impact factor: 14.307

View more
  23 in total

1.  Immunomodulatory and therapeutic properties of FK-565 in mice.

Authors:  J E Talmadge; B Lenz; M Schneider; H Phillips; C Long
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Effect of muramyl peptides on mitochondrial respiration.

Authors:  N El-Jamal; G M Bahr; K S Echtay
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

3.  Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide.

Authors:  L T Meltzer; K A Serpa; W H Moos
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Response of body temperature and serum iron concentration to repeated pyrogen injection in rabbits.

Authors:  K Goelst; H Laburn
Journal:  Pflugers Arch       Date:  1991-02       Impact factor: 3.657

5.  Two adjuvant-active muramyl dipeptide analogs induce differential production of lymphocyte-activating factor and a factor causing distress in guinea pigs.

Authors:  N E Byars
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Bayliss-Starling Memorial Lecture (1982). Induction of sleep by muramyl peptides.

Authors:  J R Pappenheimer
Journal:  J Physiol       Date:  1983-03       Impact factor: 5.182

Review 7.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

8.  Peptidoglycan fragments decrease food intake and body weight gain in rats.

Authors:  K J Biberstine; R S Rosenthal
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Stimulatory effect of N-acetyl Muramyl dipeptide in vivo: proliferation of bone marrow progenitor cells in mice.

Authors:  B Wuest; E D Wachsmuth
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

10.  Apyrogenic synthetic desmuramyldipeptide, LK-409, with immunomodulatory properties.

Authors:  M Sollner; V Kotnik; S Pecar; A Stace; S Simcic; L Povsic; B Herzog-Wraber; L Klampfer; A Ihan; P Grosman
Journal:  Agents Actions       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.